Healthcare / Medical Care FacilitiesHKSE
$2.09
+0.01 (+0.48%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $174.9M · quality 51.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
56/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.0B
P/E
12.3x
↓EV/EBITDA
2.2x
↓ROE
9.4%
↑Gross Margin
66.0%
↑Debt/Equity
0.62
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.6%
FCF CAGR
—
FCF margin
26.4%
FCF / Net income
6.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.81B · net income $73.7M · FCF $476.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.81B | $1.81B | $1.80B | $1.78B | $1.41B |
| Net Income | $73.7M | $73.7M | $-226.3M | $-546.4M | $-85.9M |
| EBITDA | $372.2M | $372.2M | $101.1M | $-196.2M | $166.4M |
| EPS | 0.15 | 0.15 | -0.45 | -1.08 | -0.16 |
| Gross Margin | 66.0% | 66.0% | 60.1% | 56.1% | 61.8% |
| Operating Margin | 7.3% | 7.3% | -6.9% | -25.4% | -11.4% |
| Net Margin | 4.1% | 4.1% | -12.5% | -30.7% | -6.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.62 | 0.62 | 0.93 | 1.16 | 0.65 |
| Current Ratio | 1.55 | 1.55 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $476.6M | $476.6M | $174.9M | $-188.5M | $-352.1M |
| Returns | |||||
| ROE | 9.4% | 9.4% | -31.7% | -58.0% | -5.4% |
| Valuation | |||||
| P/E | 12.29 | 12.29 | — | — | — |
| EV/EBITDA | 2.23 | 2.23 | 6.03 | — | 37.03 |
| P/B | 1.33 | 1.33 | 0.60 | 1.21 | 3.59 |
| Growth & Yield | |||||
| Revenue Growth | 0.2% | 0.2% | 1.5% | 25.8% | — |
| EPS Growth | 133.3% | 133.3% | 58.3% | -575.0% | — |
| Dividend Yield | 4.1% | 4.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
7.3%
EPS terminal req.
$0.19
Spread vs growth
126.0%
5Y implied EPS CAGR
8.4%
EPS terminal req.
$0.22
Spread vs growth
124.9%
10Y implied EPS CAGR
9.2%
EPS terminal req.
$0.36
Spread vs growth
124.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+92.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.45 → 0.15
Residual
+88.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.